Prof. Lorraine O’Driscoll BSc(Hons Pharmacol), MSc(Clinical Pharmacol), MA(Ed), PhD(Biotech), FTCD, FRSB, MRIA, is Chair of Pharmacology and Biomedicine, School of Pharmacy and Pharmaceutical Sciences, TCD & Research Lead of the OECI-designated Trinity St. James’s Cancer Institute (TSJCI) cancer centre. Lorraine has served two terms on the Board of Directors of the International Society for Extracellular Vesicles (ISEV) and is Chair of ISEV’s Annual Conferences in 2021 and in 2022. Lorraine was Founding Director of the H2020-funded Consortium entitled Microvesicles and Exosomes in Health and Disease, which brought together 360 researchers from industry, academic and clinics in 31 countries. She is PI/Director of a €3.9Mi H2020-MSCA-ITN TRAIN-EV, training 15xPhD students and including 5 academic and 7 industry partners and she is one of 12 recipients, across all disciplines, of a €1M Irish Research Council Advanced Laureate Award; the only female recipient in STEM. Lorraine led the recently announced proposal for a €4Mi North-South emerging hub of excellence, the All-Ireland Cancer Liquid Biopsies Consortium (CLuB), a collaboration between TCD, QUB and NUIG. She is also the TCD PI/Partner on the North-South All-Island Cancer Research Institute (AICRI)Start, led by UCD. Her group’s research has resulted in clinical trials, patents, and publications including New Engl. J. Medicine, Cancer Research, Molecular Cancer, JEV, Nature Methods. Lorraine has supervised 29 PhD students to completion. A highlight of the many things that Lorraine loves about her job is working with a fantastic research group and with patient representatives.